China has a chokehold on your medicine cabinet. It’s a national security threat

The United States produces approximately 3% of active pharmaceutical ingredients globally, while China produces approximately 45%, according to data cited by U.S. policymakers. This concentration of pharmaceutical manufacturing in China has prompted U.S. government officials to examine domestic drug supply vulnerabilities. The Department of Health and Human Services and Department of Defense have raised concerns about reliance on foreign sources for essential medications.

Next story